{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:02:41Z","timestamp":1791266561591,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","award":["PHRCI 2015, n\u00b015-059"],"award-info":[{"award-number":["PHRCI 2015, n\u00b015-059"]}],"id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Optimal management of severe trauma patients with active hemorrhage relies on adequate initial resuscitation. Early administration of coagulation factors improves post-traumatic coagulation disorders, and four-factor prothrombin complex concentrate (PCC) might be useful in this context. Our main hypothesis is that four-factor PCC in addition to a massive transfusion protocol decreases blood product consumption at day 1 in severe trauma patients with major bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a prospective, randomized, multicenter, double-blind, parallel, controlled superiority trial. Eligible patients are trauma patients with major bleeding admitted to a French level-I trauma center. Patients randomized in the treatment arm receive 1 mL\/kg (25 IU\/ml of Factor IX\/Kg) four-factor PCC within 1-h post-admission while patients randomized in the controlled group receive 1 mL\/kg of saline solution 0.9% as a placebo. Treatments are given as soon as possible using syringe pumps (120 mL\/h). The primary endpoint is the amount of blood products transfused in the first 24 h post-admission (including red blood cells, frozen fresh plasma, and platelets). The secondary endpoints are the amount of each blood product transfused in the first 24 h, time to achieve prothrombin time ratio &lt; 1.5, time to hemostasis, number of thrombo-embolic events at 28 days, mortality at 24 h and 28 days, number of intensive care unit-free days, number of ventilator-free days, number of hospital-free days within the first 28 days, hospitalization status at day 28, Glasgow outcome scale extended for patients with brain lesions on initial cerebral imaging, and cost of each strategy at days 8 and 28. Inclusions have started in December 2017 and are expected to be complete by June 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>If PCC reduces total blood consumption at day 1 after severe trauma, this therapy, in adjunction to a classic massive transfusion protocol, may be used empirically on admission in patients at risk of massive transfusion to enhance coagulation. Moreover, this treatment may decrease blood product-related complications and may improve clinical outcomes after post-traumatic hemorrhage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ClinicalTrials.gov<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03218722\">NCT03218722<\/jats:ext-link>. Registered on July 14, 2017<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-021-05524-x","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:53Z","timestamp":1631793773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study"],"prefix":"10.1186","volume":"22","author":[{"given":"Pierre","family":"Bouzat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Bosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-St\u00e9phane","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Payen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PROCOAG study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrice","family":"Levrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa\u00ebr-Selim","family":"Abback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Duranteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Garrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Marcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-St\u00e9phane","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Charbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Asehnoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Pottecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bouzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"1","key":"5524_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SLA.0b013e3181df0401","volume":"252","author":"JP Minei","year":"2010","unstructured":"Minei JP, Schmicker RH, Kerby JD, Stiell IG, Schreiber MA, Bulger E, et al. Severe traumatic injury: regional variation in incidence and outcome. Ann Surg. 2010;252(1):149\u201357. https:\/\/doi.org\/10.1097\/SLA.0b013e3181df0401.","journal-title":"Ann Surg."},{"issue":"1","key":"5524_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00268-009-0266-1","volume":"34","author":"JA Evans","year":"2010","unstructured":"Evans JA, van Wessem KJ, McDougall D, Lee KA, Lyons T, Balogh ZJ. Epidemiology of traumatic deaths: comprehensive population-based assessment. World J Surg. 2010;34(1):158\u201363. https:\/\/doi.org\/10.1007\/s00268-009-0266-1.","journal-title":"World J Surg."},{"issue":"3","key":"5524_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/SLA.0000000000000837","volume":"261","author":"SA Tisherman","year":"2015","unstructured":"Tisherman SA, Schmicker RH, Brasel KJ, Bulger EM, Kerby JD, Minei JP, et al. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. Ann Surg. 2015;261(3):586\u201390. https:\/\/doi.org\/10.1097\/SLA.0000000000000837.","journal-title":"Ann Surg."},{"issue":"2","key":"5524_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/TA.0b013e3180324124","volume":"62","author":"JB Holcomb","year":"2007","unstructured":"Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307\u201310. https:\/\/doi.org\/10.1097\/TA.0b013e3180324124.","journal-title":"J Trauma."},{"issue":"5","key":"5524_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471\u201382. https:\/\/doi.org\/10.1001\/jama.2015.12.","journal-title":"JAMA."},{"issue":"1","key":"5524_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","volume":"23","author":"DR Spahn","year":"2019","unstructured":"Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98. https:\/\/doi.org\/10.1186\/s13054-019-2347-3.","journal-title":"Crit Care."},{"issue":"4","key":"5524_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1056\/NEJMoa1802345","volume":"379","author":"JL Sperry","year":"2018","unstructured":"Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;379(4):315\u201326. https:\/\/doi.org\/10.1056\/NEJMoa1802345.","journal-title":"N Engl J Med."},{"issue":"2","key":"5524_CR8","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/cc10078","volume":"15","author":"H Schochl","year":"2011","unstructured":"Schochl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011;15(2):R83. https:\/\/doi.org\/10.1186\/cc10078.","journal-title":"Crit Care."},{"issue":"2","key":"5524_CR9","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1186\/cc8948","volume":"14","author":"H Schochl","year":"2010","unstructured":"Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55. https:\/\/doi.org\/10.1186\/cc8948.","journal-title":"Crit Care."},{"issue":"7","key":"5524_CR10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/000313480206800702","volume":"68","author":"JA Claridge","year":"2002","unstructured":"Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 2002;68(7):566\u201372.","journal-title":"Am Surg."},{"issue":"6","key":"5524_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/archsurg.1997.01430300062013","volume":"132","author":"FA Moore","year":"1997","unstructured":"Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132(6):620\u20134; discussion 4-5. https:\/\/doi.org\/10.1001\/archsurg.1997.01430300062013.","journal-title":"Arch Surg."},{"issue":"6","key":"5524_CR12","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","volume":"4","author":"P Innerhofer","year":"2017","unstructured":"Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258\u2013e71. https:\/\/doi.org\/10.1016\/S2352-3026(17)30077-7.","journal-title":"Lancet Haematol."},{"issue":"8","key":"5524_CR13","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00268-014-2631-y","volume":"38","author":"B Joseph","year":"2014","unstructured":"Joseph B, Aziz H, Pandit V, Hays D, Kulvatunyou N, Yousuf Z, et al. Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? World J Surg. 2014;38(8):1875\u201381. https:\/\/doi.org\/10.1007\/s00268-014-2631-y.","journal-title":"World J Surg."},{"issue":"2","key":"5524_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/TA.0b013e3181961c35","volume":"66","author":"TC Nunez","year":"2009","unstructured":"Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009;66(2):346\u201352. https:\/\/doi.org\/10.1097\/TA.0b013e3181961c35.","journal-title":"J Trauma."},{"issue":"4","key":"5524_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/bja\/aew276","volume":"117","author":"JF Payen","year":"2016","unstructured":"Payen JF, Berthet M, Genty C, Declety P, Garrigue-Huet D, Morel N, et al. Reduced mortality by meeting guideline criteria before using recombinant activated factor VII in severe trauma patients with massive bleeding. Br J Anaesth. 2016;117(4):470\u20136. https:\/\/doi.org\/10.1093\/bja\/aew276.","journal-title":"Br J Anaesth."},{"issue":"1","key":"5524_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","volume":"20","author":"R Rossaint","year":"2016","unstructured":"Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20(1):100. https:\/\/doi.org\/10.1186\/s13054-016-1265-x.","journal-title":"Crit Care."},{"issue":"9734","key":"5524_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"collaborators C-t, Shakur H, Robert","year":"2010","unstructured":"collaborators C-t, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23\u201332.","journal-title":"Lancet."},{"issue":"1","key":"5524_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13049-018-0523-0","volume":"26","author":"P Bouzat","year":"2018","unstructured":"Bouzat P, Ageron FX, Charbit J, Bobbia X, Deras P, Nugues JBD, et al. Modelling the association between fibrinogen concentration on admission and mortality in patients with massive transfusion after severe trauma: an analysis of a large regional database. Scand J Trauma Resusc Emerg Med. 2018;26(1):55. https:\/\/doi.org\/10.1186\/s13049-018-0523-0.","journal-title":"Scand J Trauma Resusc Emerg Med."},{"key":"5524_CR19","doi-asserted-by":"crossref","unstructured":"Bouzat P, Guerin R, Boussat B, Nicolas J, Lambert A, Greze J, et al. Diagnostic performance of thromboelastometry in trauma-induced coagulopathy: a comparison between two level I trauma centres using two different devices. Eur J Trauma Emerg Surg. 2021;47(2):343\u201351","DOI":"10.1007\/s00068-019-01165-7"},{"issue":"11","key":"5524_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamasurg.2019.2884","volume":"154","author":"CA Sims","year":"2019","unstructured":"Sims CA, Holena D, Kim P, Pascual J, Smith B, Martin N, et al. Effect of low-dose supplementation of arginine vasopressin on need for blood product transfusions in patients with trauma and hemorrhagic shock: a randomized clinical trial. JAMA Surg. 2019;154(11):994\u20131003. https:\/\/doi.org\/10.1001\/jamasurg.2019.2884.","journal-title":"JAMA Surg."},{"issue":"5","key":"5524_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/01.TA.0000022460.21283.53","volume":"54","author":"GE Hill","year":"2003","unstructured":"Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54(5):908\u201314. https:\/\/doi.org\/10.1097\/01.TA.0000022460.21283.53.","journal-title":"J Trauma."},{"issue":"6","key":"5524_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.injury.2016.02.027","volume":"47","author":"I Sammy","year":"2016","unstructured":"Sammy I, Lecky F, Sutton A, Leaviss J, O'Cathain A. Factors affecting mortality in older trauma patients-a systematic review and meta-analysis. Injury. 2016;47(6):1170\u201383. https:\/\/doi.org\/10.1016\/j.injury.2016.02.027.","journal-title":"Injury."},{"issue":"1","key":"5524_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","volume":"10","author":"D Moher","year":"2012","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10(1):28\u201355. https:\/\/doi.org\/10.1016\/j.ijsu.2011.10.001.","journal-title":"Int J Surg."},{"issue":"3","key":"5524_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.surg.2012.06.008","volume":"152","author":"WB Al-Refaie","year":"2012","unstructured":"Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB. Blood transfusion and cancer surgery outcomes: a continued reason for concern. Surgery. 2012;152(3):344\u201354. https:\/\/doi.org\/10.1016\/j.surg.2012.06.008.","journal-title":"Surgery."},{"issue":"2","key":"5524_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/ALN.0b013e3182054d06","volume":"114","author":"LG Glance","year":"2011","unstructured":"Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011;114(2):283\u201392. https:\/\/doi.org\/10.1097\/ALN.0b013e3182054d06.","journal-title":"Anesthesiology."},{"issue":"8","key":"5524_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s12630-013-9937-3","volume":"60","author":"A Turan","year":"2013","unstructured":"Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, et al. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth. 2013;60(8):761\u201370. https:\/\/doi.org\/10.1007\/s12630-013-9937-3.","journal-title":"Can J Anaesth."},{"issue":"6","key":"5524_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/archsurg.137.6.711","volume":"137","author":"PJ Offner","year":"2002","unstructured":"Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg. 2002;137(6):711\u20136; discussion 6-7. https:\/\/doi.org\/10.1001\/archsurg.137.6.711.","journal-title":"Arch Surg."},{"key":"5524_CR28","doi-asserted-by":"crossref","unstructured":"Gratz J, Schlimp CJ, Honickel M, Hochhausen N, Schochl H, Grottke O. Sufficient thrombin generation despite 95% hemodilution: an in vitro experimental study. J Clin Med. 2020;9(12):3805.","DOI":"10.3390\/jcm9123805"},{"issue":"10","key":"5524_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/EJA.0000000000001202","volume":"37","author":"J Gratz","year":"2020","unstructured":"Gratz J, Ponschab M, Iapichino GE, Schlimp CJ, Cadamuro J, Grottke O, et al. Comparison of fresh frozen plasma vs. coagulation factor concentrates for reconstitution of blood: an in vitro study. Eur J Anaesthesiol. 2020;37(10):879\u201388. https:\/\/doi.org\/10.1097\/EJA.0000000000001202.","journal-title":"Eur J Anaesthesiol."},{"issue":"4","key":"5524_CR30","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/cc13982","volume":"18","author":"H Schochl","year":"2014","unstructured":"Schochl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care. 2014;18(4):R147. https:\/\/doi.org\/10.1186\/cc13982.","journal-title":"Crit Care."},{"issue":"6","key":"5524_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.accpm.2018.10.013","volume":"37","author":"E Toulouse","year":"2018","unstructured":"Toulouse E, Masseguin C, Lafont B, McGurk G, Harbonn A, JAR, et al. French legal approach to clinical research. Anaesth Crit Care Pain Med. 2018;37(6):607\u201314. https:\/\/doi.org\/10.1016\/j.accpm.2018.10.013.","journal-title":"Anaesth Crit Care Pain Med."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05524-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05524-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:29:01Z","timestamp":1673263741000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05524-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5524"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05524-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Protocol was approved by the Institutional Review Board Sud-Ouest et Outre Mer II (SOOM II), on <i>June 04, 2017,<\/i> and authorized by the French competent authority (Agence Nationale pour la S\u00e9curit\u00e9 du M\u00e9dicament, ANSM) on <i>April 04, 2017<\/i>. The study is carried out following Good Clinical Practices, the principles of the declaration of Helsinki and European legislation []. Because of selection criteria, some enrolled patients are unable to consent (e.g., unconsciousness, agitation, post-traumatic stress). Informed consent can be therefore obtained from patient\u2019s next of kin if present or consent is waived if no one is present at the time of enrolment, as authorized by French law in an emergency situation and approved by the ethics committee. This procedure was already used and authorized in a previous French study on trauma []. As soon as the patient\u2019s next of kin is available and capable of informed consent in complete and faithful terms, consent is obtained. Informed consent must also be obtained from the patient whenever he\/she becomes able to consent and up to 28 days after trauma. Patients and their next of kin have the right to refuse to participate in the study or revoke their consent at any time. All information appears in an information notice and a consent form given to the subject. All these documents have been approved by the ethics committee. Written informed consent is obtained by the investigator. Two original copies are co-signed by both the investigator and the subject who consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Although it is not anticipated, owing to the trial design, publication of any personal information about a patient will require her\/his consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"PB, JSD, BR, JD, and JFP received payments from LFB, Les Ullis, France, for lectures and educational content. The other author declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"634"}}